Data surrounding the TETs are particularly limited in rarer cancer types; however, somatic TET2 mutations have been described in a number of these settings, including salivary duct carcinoma [54], penile squamous cell carcinoma [105], parathyroid carcinoma [106], and oligoastrocytoma [56]. Here, TET2 is linked to cancer.